NASOPENPE (GM Pharmaceuticals, Inc)


Welcome to the PulseAid listing for the NASOPEN drug offered from GM Pharmaceuticals, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: GM Pharmaceuticals, Inc
NON-PROPRIETARY NAME: Phenylephrine Hydrochloride, Thonzylamine Hydrochloride
SUBSTANCE NAME: PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2012-10-03
END MARKETING DATE: 0000-00-00


NASOPEN PE HUMAN OTC DRUG Details:

Item DescriptionNASOPEN PE from GM Pharmaceuticals, Inc
LABELER NAME: GM Pharmaceuticals, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 10; 50(mg/15mL; mg/15mL)
START MARKETING DATE: 2012-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58809-729_44c2c20b-fdd4-41b4-b4f1-50131bb056b2
PRODUCT NDC: 58809-729
APPLICATION NUMBER: part341

Other PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GM Pharmaceuticals, IncNASOPEN